SEATTLE, July 18, 2017 -- Trupanion, Inc. (Nasdaq:TRUP), a leading provider of medical insurance for cats and dogs, announced today it will report financial results for its 2017 second quarter after the market closes on Tuesday, August 1, 2017. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET.
A live webcast will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call.
Participants can access the conference call by dialing 1-877-407-0784 (United States) or 1-201-689-8560 (International). A telephonic replay of the call will also be available, one hour after the completion of the call, by dialing 1-844-512-2921 (United States) or 1-412-317-6671 (International) and entering the replay pin number: 13666206.
About Trupanion:
Trupanion is a leading provider of medical insurance for cats and dogs throughout the United States and Canada. For almost two decades, Trupanion has given pet owners peace of mind so they can focus on their pet’s recovery, not financial stress. Trupanion is committed to providing pet owners with the highest value in pet medical insurance. Trupanion is listed on the Nasdaq Stock Exchange under the symbol TRUP. The company was founded in 2000 and is headquartered in Seattle, WA. Trupanion policies are issued, in the United States, by its wholly-owned insurance entity American Pet Insurance Company and, in Canada, by Omega General Insurance Company. For more information please visit Trupanion.com.
Contacts: Investors: Laura Bainbridge, Addo Investor Relations 310.829.5400 [email protected] Media: Scott Janzen, Trupanion Director of Communications 888.612.1138 ext 3450 [email protected]


Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Apple Turns 50: From Garage Startup to AI Crossroads
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 



